Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
André, T., Lonardi, S., Wong, K.Y.M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M.A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M.B., Hendlisz, A., Neyns, B., Abdullaev, S., Memaj, A., Lei, M., Dixon, M., Kopetz, S., Overman, M.J.
Published in Annals of oncology (01.10.2022)
Published in Annals of oncology (01.10.2022)
Get full text
Journal Article
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
Reck, M., Ciuleanu, T.-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Felip, E., Juan-Vidal, O., Alexandru, A., Sakai, H., Lingua, A., Reyes, F., Souquet, P.-J., De Marchi, P., Martin, C., Pérol, M., Scherpereel, A., Lu, S., Paz-Ares, L., Carbone, D.P., Memaj, A., Marimuthu, S., Zhang, X., Tran, P., John, T.
Published in ESMO open (01.10.2021)
Published in ESMO open (01.10.2021)
Get full text
Journal Article
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis
Borghaei, H., Ciuleanu, T.-E., Lee, J.-S., Pluzanski, A., Caro, R. Bernabe, Gutierrez, M., Ohe, Y., Nishio, M., Goldman, J., Ready, N., Spigel, D.R., Ramalingam, S.S., Paz-Ares, L.G., Gainor, J.F., Ahmed, S., Reck, M., Maio, M., O’Byrne, K.J., Memaj, A., Nathan, F., Tran, P., Hellmann, M.D., Brahmer, J.R.
Published in Annals of oncology (01.02.2023)
Published in Annals of oncology (01.02.2023)
Get full text
Journal Article
Corrigendum to ‘First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update’: [ESMO Open Volume 6, Issue 5, October 2021, 100273]
Reck, M., Ciuleanu, T.-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Felip, E., Juan-Vidal, O., Alexandru, A., Sakai, H., Lingua, A., Reyes, F., Souquet, P.-J., De Marchi, P., Martin, C., Pérol, M., Scherpereel, A., Lu, S., Paz-Ares, L., Carbone, D.P., Memaj, A., Marimuthu, S., Zhang, X., Tran, P., John, T.
Published in ESMO open (01.12.2021)
Published in ESMO open (01.12.2021)
Get full text
Journal Article
DOP43 Rapidity of ozanimod-induced symptomatic response and remission in patients with moderately to severely active Ulcerative Colitis: Results from the induction period of True North
Siegmund, B, Axelrad, J, Pondel, M, Osterman, M T, Ahmad, H A, Memaj, A, Regueiro, M, Armuzzi, A, Afzali, A
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
SO-27 Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
André, T., Lonardi, S., Wong, K., Lenz, H., Gelsomino, F., Aglietta, M., Morse, M., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M., Hendlisz, A., Neyns, B., Abdullaev, S., Memaj, A., Lei, M., Kopetz, S., Overman, M.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
P585 Duration of response to ozanimod after treatment withdrawal: results from the phase 3 True North study
Vermeire, S, Abraham, B, Bressler, B, Reinisch, W, Jain, A, Memaj, A, Akukwe, L, Liu, W J, Osterman, M, Canavan, J B, Sands, B E
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P752 Predictors of time to relapse upon ozanimod withdrawal in patients with moderately to severely active ulcerative colitis
Vermeire, S, Abraham, B, Bressler, B, Reinisch, W, Axelrad, J E, Jain, A, Memaj, A, Akukwe, L, Liu, W J, Osterman, M T, Canavan, J B, Sands, B E
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
Corrigendum to ‘First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update’: ESMO Open Volume 6, Issue 5, October 2021, 100273
Reck, M., Ciuleanu, T.-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Felip, E., Juan-Vidal, O., Alexandru, A., Sakai, H., Lingua, A., Reyes, F., Souquet, P.-J., De Marchi, P., Martin, C., Pérol, M., Scherpereel, A., Lu, S., Paz-Ares, L., Carbone, D.P., Memaj, A., Marimuthu, S., Zhang, X., Tran, P., John, T.
Published in ESMO open (02.12.2021)
Published in ESMO open (02.12.2021)
Get full text
Journal Article